Showing 31-34 of 34 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Reducing Health Disparities and Improving Outcomes in Type 1 Diabetes Through a Novel Community-Focused Digital Care Model | Blue Circle Health | Leonard D’Avolio | Mission | 01-January-2026 to 31-December-2028 | $1,500,000.00 |
| New lipid biomarker to predict early risk for Type 1 diabetes | Beth Israel Deaconess Medical Center Inc | Barbara Kahn | Cures | 01-September-2024 to 31-August-2027 | $899,997.53 |
| Integration of Slow-Release A1AT-loaded Nanoparticles for Enhanced Cell Therapy in Type 1 Diabetes | Beth Israel Deaconess Medical Center Inc | Giuseppe Pettinato | Cures | 01-October-2024 to 31-July-2026 | $200,000.00 |
| Phase II Study of Oral HLA DQ8 Inhibitor in Adults with Type-I Diabetes | Aurimi Therapeutics | Nandan Padukone | Cures | 01-September-2026 to 31-August-2030 | $1,900,000.00 |